Date | Time | Source | Headline | Symbol | Company |
04/15/2024 | 4:30PM | Business Wire | Novo Integrated Sciences Reports Fiscal Year 2024 Second Quarter Financial Results | NASDAQ:NVOS | Novo Integrated Sciences Inc |
04/11/2024 | 5:00PM | Business Wire | Novo Integrated Sciences Closes on $6,210,000 Securities Purchase Agreement | NASDAQ:NVOS | Novo Integrated Sciences Inc |
03/26/2024 | 2:30PM | Business Wire | Novo Integrated Sciences Provides Update on Certain Current Actions and Events | NASDAQ:NVOS | Novo Integrated Sciences Inc |
02/21/2024 | 4:05PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:NVOS | Novo Integrated Sciences Inc |
02/21/2024 | 4:05PM | Business Wire | Novo Integrated Sciences Subsidiary, Clinical Consultants International, Signs Agreement with Futura Surgicare Pvt Ltd. | NASDAQ:NVOS | Novo Integrated Sciences Inc |
02/20/2024 | 2:00PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:NVOS | Novo Integrated Sciences Inc |
02/20/2024 | 2:00PM | Business Wire | Novo Integrated Sciences Receives Limited Waiver to Securities Purchase Agreement for $70,000,000 Promissory Note | NASDAQ:NVOS | Novo Integrated Sciences Inc |
02/16/2024 | 2:00PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:NVOS | Novo Integrated Sciences Inc |
02/16/2024 | 2:00PM | Business Wire | Novo Integrated Sciences Appoints New President | NASDAQ:NVOS | Novo Integrated Sciences Inc |
02/15/2024 | 5:00PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:NVOS | Novo Integrated Sciences Inc |
02/06/2024 | 12:00PM | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] | NASDAQ:NVOS | Novo Integrated Sciences Inc |
01/22/2024 | 4:31PM | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:NVOS | Novo Integrated Sciences Inc |
01/22/2024 | 4:30PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:NVOS | Novo Integrated Sciences Inc |
01/22/2024 | 4:30PM | Business Wire | Novo Integrated Sciences Reports Fiscal Year 2024 First Quarter Financial Results | NASDAQ:NVOS | Novo Integrated Sciences Inc |
01/16/2024 | 4:05PM | Edgar (US Regulatory) | Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB | NASDAQ:NVOS | Novo Integrated Sciences Inc |
12/19/2023 | 4:45PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:NVOS | Novo Integrated Sciences Inc |
12/19/2023 | 4:30PM | Business Wire | Blacksheep Trust Files Partial Assignment of $1 Billion Dollar Gold Backed Bond to Novo Integrated Sciences | NASDAQ:NVOS | Novo Integrated Sciences Inc |
12/14/2023 | 5:01PM | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] | NASDAQ:NVOS | Novo Integrated Sciences Inc |
12/14/2023 | 5:00PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:NVOS | Novo Integrated Sciences Inc |
12/14/2023 | 5:00PM | Business Wire | Novo Integrated Sciences Reports 2023 Fiscal Year Financial Results | NASDAQ:NVOS | Novo Integrated Sciences Inc |
12/05/2023 | 1:20PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:NVOS | Novo Integrated Sciences Inc |
12/05/2023 | 12:00PM | Business Wire | Novo Integrated Sciences Signs Master Collaboration Agreement with Psychocare Health Pvt. Ltd. India | NASDAQ:NVOS | Novo Integrated Sciences Inc |
12/04/2023 | 11:30AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:NVOS | Novo Integrated Sciences Inc |
12/04/2023 | 11:30AM | Business Wire | Novo Integrated Sciences’ Purchase and Sale Agreement to Acquire Ophir Collection Receives Court Approval | NASDAQ:NVOS | Novo Integrated Sciences Inc |
11/29/2023 | 4:05PM | Edgar (US Regulatory) | Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | NASDAQ:NVOS | Novo Integrated Sciences Inc |
11/27/2023 | 9:25AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:NVOS | Novo Integrated Sciences Inc |
11/24/2023 | 9:20AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:NVOS | Novo Integrated Sciences Inc |
11/24/2023 | 9:20AM | Business Wire | Novo Integrated Sciences Regains Compliance with Nasdaq Minimum Bid Price Requirement | NASDAQ:NVOS | Novo Integrated Sciences Inc |
11/06/2023 | 11:59AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:NVOS | Novo Integrated Sciences Inc |
11/06/2023 | 11:45AM | Business Wire | Novo Integrated Sciences Announces Reverse Stock Split | NASDAQ:NVOS | Novo Integrated Sciences Inc |